Metabolic research
GLP-3 (Retatrutide)
2 publications
Human phase 2
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes
Compound research profiles
Every study, broken down by compound.
Choose a compound to review each publication separately, including its evidence category, research model, scope, interpretation limits, and original source.
Evidence categories matter
Animal, cell, and review findings are not proof of safety or effectiveness in humans. Publications are educational references—not product validation, dosing guidance, medical advice, or instructions for use.
15 compounds · 31 publications
Original summaries · Direct sources
View research breakdown
Metabolic research
GLP-2 (Tirzepatide)
2 publications
Human phase 3
Tirzepatide Once Weekly for the Treatment of Obesity
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Metabolic research
GLP-1 (Semaglutide)
2 publications
Human phase 3
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Metabolic research
Cagrilintide
2 publications
Human phase 2Human clinical
Once-weekly cagrilintide for weight management: a dose-finding phase 2 trial
Coadministration of cagrilintide and semaglutide: a randomized phase 1b trial
Secretagogue research
Tesamorelin
2 publications
Human clinical
Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients
Secretagogue research
CJC-1295
3 publications
Human pharmacologyPreclinical
Prolonged stimulation of GH and IGF-I levels by CJC-1295 in healthy adults
Pharmacokinetic-pharmacodynamic modeling of ipamorelin in healthy volunteers
Cell and tissue models
BPC-157
2 publications
Preclinical
BPC-157 and growth hormone receptor expression in injured tendon tissue
BPC-157 enhances healing in an alkali-burn corneal injury model
Cell and tissue models
TB-500 / Thymosin β4
2 publications
Preclinical
Thymosin beta4 accelerates wound healing
Thymosin beta 4 and its actin-binding domain promote dermal wound repair
Dermal and cellular research
GHK-Cu
2 publications
Review
Regenerative and Protective Actions of the GHK-Cu Peptide in Light of New Gene Data
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways
Cell and tissue models
KPV
2 publications
Preclinical
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
KPV has anti-inflammatory potential in murine models of intestinal inflammation
Metabolic research
MOTS-C
2 publications
PreclinicalHuman pharmacology
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline
Neuroscience research
Semax
2 publications
Human clinical
Semax in early rehabilitation of patients with ischemic stroke
Effectiveness of Semax in the acute period of hemispheric ischemic stroke
Neuroscience research
Selank
2 publications
Human clinical
Comparison of Selank and phenazepam in anxiety disorders
Efficacy and possible mechanisms of Selank in generalized anxiety and neurasthenia
Cellular metabolism
NAD+
2 publications
Review
NAD+ therapy in age-related degenerative disorders: a benefit/risk analysis
NAD+ Metabolism in Cardiac Health, Aging, and Disease
Redox research
Glutathione
2 publications
Human clinical
Randomized controlled trial of oral glutathione supplementation on body stores
Effects of oral glutathione supplementation on systemic oxidative stress biomarkers